Overview
Announcements

Ordinary Adjustment | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th January 2026

Solactive Transatlantic Healthcare Equity Index:

In the ordinary adjustment, the following composition will be implemented effective open 8th January 2026:

ABBOTT LABORATORIES
ABBVIE INC
ALCON INC
AMGEN INC
BECTON DICKINSON AND CO
BIOMERIEUX
BOSTON SCIENTIFIC CORP
BRISTOL-MYERS SQUIBB CO
COLOPLAST AS CLASS B
CONCENTRA GROUP HOLDINGS PARENT ORD
DANAHER CORP
EDWARDS LIFESCIENCES CORP
ENCOMPASS HEALTH CORP
ENSIGN GROUP INC
FRESENIUS MEDICAL CARE AG & CO KGAA
GALDERMA GROUP AG
GETINGE AB CLASS B
GILEAD SCIENCES INC
GRIFOLS SA CLASS A
GSK PLC
HALEON PLC
HALOZYME THERAPEUTICS INC
HOLOGIC INC
IPSEN SA
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
LABCORP HOLDINGS INC
LEMAITRE VASCULAR INC
LONZA GROUP AG
MEDTRONIC PLC
MERCK KGAA
MERIT MEDICAL SYSTEMS INC
METTLER-TOLEDO INTL
NOVARTIS AG
ORION OYJ CLASS B
PFIZER INC
PRESTIGE CONSUMER HEALTHCARE INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RECORDATI SPA
RESMED INC
ROCHE HOLDING AG
SANOFI SA
SIEMENS HEALTHINEERS AG
SOLVENTUM CORP
SONOVA HOLDING AG
STERIS PLC
STRYKER CORP
SWEDISH ORPHAN BIOVITRUM AB
ZOETIS INC